Early trials suggest GLP-1 drugs may improve PMOS symptoms, but the studies are small, and insurers rarely cover the off-label use.
Obesity Drugs Ease PMOS Symptoms in Small Trials, but Insurance Denials Keep Many Patients from Getting Them
by | Aug 16, 2026 | Uncategorized | 0 comments

Recent Comments